Clinical Observation on Treatment of Senile Chronic Congestive Heart Failure with Shenmai Injection plus Potassium Magnessium Aspartape
10.3760/cma.j.issn.1673-4246.2009.01.013
- VernacularTitle:参麦注射液联合门冬氨酸钾镁治疗老年慢性充血性心力衰竭的疗效观察
- Author:
Fengmin GAO
;
Shuangli HUANG
;
Junzi CONG
- Publication Type:Journal Article
- Keywords:
Senile congestive cardiac failure;
Shenmai Inj;
Potassium Magnesium Asparaginate
- From:
International Journal of Traditional Chinese Medicine
2009;31(1):27-28
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe curative effect of treating senile Chronic Congestive Heart Failum(CCHF)with Shenmai Inj.plus Potassium Magnesium Asparaginate.Methods 91 patients with senile CCHF were randomly recruited into a treatment group and a control group.The control group was treated with Digoxin,Hydrochiorothiazide,Spironolacmne,Captopril,and Metoprolol taken orally.The treatment group was treated with Shenmai Injection plus Potassmm Jagrnesium Aspartate besides treatments of the control group.Both groups were ordered to rest in bed and take low-salt diet and treated for one course of 14 days.Results The total effective rate of the control group was 80.0%and the total effective rate of the treatment group was 95.7%(P<0.05).The left veiltricular ejection fraction of the treatment group was improved obviously.As compared with the control group,the treatment group has significant difference(P<0.01).Conclusion n was safety and effective to treat senile CCHF with Shenmai Inj.plus Potassium Magnesium Asparaginate in addition to lessen digitalis toxic effect and prevent arrhythmia.